From: Optimising clinical effectiveness and quality along the atrial fibrillation anticoagulation pathway: an economic analysis
Variable
Mean (%) (SD (%))
TTR 6 months prior
71 (23)
TTR 3 months prior
73 (22)
TTR 6 months following
75 (17)